...
首页> 外文期刊>FEMS Microbiology Letters >Altenusin, a biphenyl isolated from the endophytic fungus Alternaria sp., inhibits trypanothione reductase from Trypanosoma cruzi
【24h】

Altenusin, a biphenyl isolated from the endophytic fungus Alternaria sp., inhibits trypanothione reductase from Trypanosoma cruzi

机译:Altenusin,一种从内生真菌Alternaria sp。分离出的联苯,抑制克氏锥虫的锥虫硫磷还原酶

获取原文
获取原文并翻译 | 示例

摘要

Parasitic protozoan species belonging to the genera Trypanosoma and Leishmania are the etiological agents of several diseases in tropical areas of the world, for which there is an urgent need for effective and affordable treatment. In this regard, we are screening the Brazilian biodiversity, especially its flora and mycota, for natural products that could serve as leads for drug development against these diseases. Trypanothione reductase (TR) is an enzyme involved in the protection of Trypanosoma and Leishmania species against oxidative stress, and is considered to be a validated drug target. The endophytic fungus Alternaria sp. (UFMGCB55) was isolated from the plant Trixis vauthieri DC (Asteraceae), known to contain trypanocidal compounds. The organic extract of the culture of Alternaria sp. was able to inhibit TR by 99%, when tested at 20 mu g mL(-1). Fractionation of the extract identified altenusin, a biphenyl derivative with an IC50 value of 4.3 +/- 0.3 mu M in the TR assay. This compound is the first in its class to have shown TR inhibitory activity, opening new perspectives for the design of more effective derivatives that could serve as drug leads for new chemotherapeutic agents to treat trypanosomiasis and leishmaniasis.
机译:属于锥虫和利什曼原虫属的原生动物是世界热带地区几种疾病的病原体,迫切需要有效和负担得起的治疗方法。在这方面,我们正在筛查巴西生物多样性,尤其是其菌群和菌丝,寻找天然产物,这些天然产物可以作为开发针对这些疾病的药物的线索。锥虫硫磷还原酶(TR)是一种涉及保护锥虫和利什曼原虫物种免受氧化应激的酶,被认为是经过验证的药物靶标。内生真菌Alternaria sp。 (UFMGCB55)从已知含有锥虫化合物的Trixis vauthieri DC(菊科)植物中分离出来。链格孢菌培养物的有机提取物。当在20μg mL(-1)中进行测试时,能够将TR抑制99%。提取物的馏分鉴定出了altenusin,这是一种联苯衍生物,在TR分析中的IC50值为4.3 +/- 0.3μM。该化合物是同类产品中第一个显示出TR抑制活性的化合物,为设计更有效的衍生物开辟了新的前景,这些衍生物可以用作治疗锥虫病和利什曼病的新型化学治疗药物的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号